Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial
- DOI
- 10.1192/bjo.2025.10968
- Published
- 2026-02-16
- Container
- BJPsych Open
- Publisher
- Royal College of Psychiatrists
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1192/bjo.2025.10968,
title = {Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial},
author = {Zeina Beidas and Anya Ragnhildstveit and Adam Blackman and Thomas Anderson and Emily Fewster and Omer A. Syed and Valentyne Sobolenko and Ismail Kaan Kanca and Magdalena Jaglinska and Tatiana Son and Norman Farb and Rotem Petranker},
year = {2026},
journal = {BJPsych Open},
doi = {10.1192/bjo.2025.10968},
url = {https://doi.org/10.1192/bjo.2025.10968}
}RIS
TY - JOUR TI - Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial AU - Zeina Beidas AU - Anya Ragnhildstveit AU - Adam Blackman AU - Thomas Anderson AU - Emily Fewster AU - Omer A. Syed AU - Valentyne Sobolenko AU - Ismail Kaan Kanca AU - Magdalena Jaglinska AU - Tatiana Son AU - Norman Farb AU - Rotem Petranker PY - 2026 JO - BJPsych Open DO - 10.1192/bjo.2025.10968 UR - https://doi.org/10.1192/bjo.2025.10968 ER -
APA
Beidas, Z., Ragnhildstveit, A., Blackman, A., Anderson, T., Fewster, E., Syed, O. A., Sobolenko, V., Kanca, I. K., Jaglinska, M., Son, T., Farb, N., & Petranker, R. (2026). Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial. BJPsych Open. https://doi.org/10.1192/bjo.2025.10968
Source records
- crossref · retrieved 2026-09-25T02:54:12.498Z